Clinical Trials Sponsored by BOIRON

Total 3137 results

Chiron Corporation

Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Adenocarcinoma | Stomach Neoplasms | Esophageal Neoplasms

United States
Chiron Corporation

Completed

Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments

Lymphoma, Non-Hodgkin

United States
Chiron Corporation

Terminated

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin Lymphoma

United States
Chiron Corporation

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis

United Kingdom
Biocon Biologics UK Ltd

Active, not recruiting

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis (DEVOTE)

Postmenopausal Women With Osteoporosis

United Kingdom
Bolton Medical
Bolton Medical Espana SLU

Terminated

An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

Aortic Aneurysm, Abdominal

Spain, Belgium, Netherlands, Germany, Italy, Switzerland, United Kingdom
Boston Children's Hospital
Boston Orthotics & Prosthetics

Completed

Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants

Plagiocephaly

United States
Boston Children's Hospital
Boston Orthotics & Prosthetics

Terminated

Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU

Plagiocephaly | Brachycephaly | Scaphocephaly

United States
Orion Corporation, Orion Pharma

Active, not recruiting

Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer (CYPIDES)

Prostate Cancer Metastatic

France, United Kingdom, Finland, United States
Orion Corporation, Orion Pharma

Terminated

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension (REFALS-ES)

Amyotrophic Lateral Sclerosis

Canada, United States, Australia, Germany, Belgium, Finland, Spain, Austria, Italy, France, Ireland, Netherlands, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product (FORELLI)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler® (TESSA)

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours (KIDES-203)

Solid Tumours

France, Finland, Spain, Italy, Denmark, United Kingdom
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax (Remo-Wax)

Cerumen Impaction of Both Ears

Lithuania
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) (COMPOC)

Parkinson's Disease

Finland, Germany, Hungary, Latvia
Orion Corporation, Orion Pharma

Completed

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Ireland, Netherlands, United Kingdom, Germany
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic of Levodopa Study in Healthy Males

Parkinson Disease

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

Heart Failure

Sweden
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Study to Evaluate Initiation of Stalevo in Early Wearing-off (SENSE)

Parkinson's Disease

Germany, Sweden, United Kingdom
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers (NOCIFIM)

Healthy

Germany
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Single Ascending Doses of ODM-102

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

Pain

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

Pain

Finland
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (SALBLOCK) (SALBLOCK)

Healthy Volunteer Study

Finland
Orion Corporation, Orion Pharma

Completed

Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens (PARTEST)

Parkinson's Disease

Finland, Sweden
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (Reco-Pilot)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Levodopa Concentration Profile With Stalevo 75/125 mg (NEWSTA)

Parkinson's Disease

Finland
Orion Corporation, Orion Pharma

Completed

Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU) (Prodex)

Continuous Sedation in Initially Sedated Adults in ICU

Finland, United Kingdom, Belgium, Germany, Netherlands, Russian Federation, Switzerland
Orion Corporation, Orion Pharma

Completed

A PET Study With ORM-12741

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study of ORM-12741 in Healthy Volunteers

Healthy Volunteers

Finland
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741

Healthy

France
Orion Corporation, Orion Pharma

Completed

Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU (DEX PK)

Pharmacokinetics | Sedation

Finland
Orion Corporation, Orion Pharma

Completed

Peroral Levosimendan in Chronic Heart Failure

Heart Diseases | Chronic Heart Failure

Finland
Orion Corporation, Orion Pharma

Terminated

Dexmedetomidine for Continuous Sedation

Conscious Sedation

Finland, Switzerland
Biocon Biologics UK Ltd

Not yet recruiting

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd

Active, not recruiting

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis (STELLAR-2)

Moderate to Severe Chronic Plaque Psoriasis

United States
Boston College

Not yet recruiting

Episodic Memory Integration and Interference

Episodic Memory

United States
Boston Pharmaceuticals

Active, not recruiting

A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis (NASH)

United States
Bolton Medical

Active, not recruiting

RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers (RelayPro-A)

Aortic Aneurysm, Thoracic | Penetrating Ulcer

United States, Japan
Bolton Medical

Active, not recruiting

Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection

Aortic Dissection Type B

United States
Boston University

Completed

Clinic-Based Atopic Dermatitis Therapeutic Patient Education (AD-TPE)

Atopic Dermatitis

United States
Boston University

Completed

Geriatric Anorexia Study 2.0 (GAS2)

Healthy | Frailty

United States
Boston University

Completed

Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19)

COVID-19

United States, Spain
Boston University

Completed

Virtual Teaching Kitchen

Metabolic Syndrome | Cardiac Health

United States
Boston IVF

Completed

Does a Brief Intervention Decrease Patient Drop Out Rates?

Infertility

United States
Boston University

Completed

Scratch Behavior Under Standard of Care (SOC)

Atopic Dermatitis

United States
Boston Pharmaceuticals

Completed

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

Chronic Plaque Psoriasis

Germany
Boston Therapeutics

Withdrawn

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients (PAZ320)

Type II Diabetes

France

Clinical Trials Sponsored by BOIRON

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations